Amlodipine and Olmesartan Medoxomil Tablets Articles
Daiichi Sankyo ups profit forecast by 13% on expected rupee gain related to Ranbaxy; files flu drug in Japan
1 February 2010
Daiichi Sankyo's Azor improves 24-hour ABP
12 May 2009
Mylan sued by Daiichi Sankyo over Azor patent
9 June 2008
Forest takes $44M hit on ending Azor deal
19 May 2008
Daiichi Sankyo and Forest finalize Azor co-promotion deal
22 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Japan stock market week to September 3, 2007
10 September 2007
Daiichi Sankyo and Forest sign US promotion deal
3 September 2007
Combined bp drug Azor discussed at ASH
28 May 2007
Showing 1-11 of 11 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
